Hsa-miR-105-5p acts as an oncogene in triple-negative breast cancer

Similar Items

• miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
  by: Hao-Yi Li, et al.
  Published: (2017-12-01)
• MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4
  by: Bo Lin, et al.
  Published: (2021-03-01)
• Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
  by: Camile B. Lopes, et al.
  Published: (2018-07-01)
• Ebola virus infection, human Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p and predicted targets
  by: Beuy Joob, et al.
  Published: (2014-12-01)
• Salivary microRNAs (hsa-miR-200a, hsa-miR-125a and hsa- miR-93) in relation to age, gender and histopathological parameters.
  by: Shaimaa H Mudhir, et al.
  Published: (2014-12-01)